QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 13,020
+270 (2.12%)
At close: Apr 23, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 149.5 billion as of April 24, 2026.
Market Cap
149.50B
Enterprise Value
129.46B
Revenue
10.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,020.00
Market Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 149.50B, a decrease of -25.23%. That is a compound annual growth rate of -55.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 149.50B | -15.45% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ISU Abxis | 197.53B |
| Prestige Biologics | 192.83B |
| Ensol Biosciences | 192.62B |
| CORESTEMCHEMON | 141.07B |
| BIO-FD&C | 123.74B |
| NovMetaPharma | 122.64B |
| ViGenCell | 116.64B |
| KoBioLabs | 110.69B |